Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users

NCT06594068 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Anifrolumab

Sponsor

AstraZeneca

Collaborators

[object Object]